Cytodyn Inc (CYDY)

[Evil Rabbit]

I think there are plenty of deals on the table but Cytodyn doesn’t want to piecemeal their product out. They want to retain 100% control over the drug and sell it as a single piece. In almost all forms of business, that makes sense. If BP wants Leronlimab they aren’t going to pay as much it territory XYZ or application XYZ has already been sold off.

That explains NP’s comments about licensing deals if BLA only pushes pps to $2-3. The deals are there but, for now at least, it doesn’t make sense to accept them.